A carregar...
Novel oral anticoagulants for atrial fibrillation
Anticoagulation therapy is effective in preventing primary and secondary thromboembolic events due to atrial fibrillation. Warfarin, which was approved by the United States in 1954, was the only long-term oral anticoagulation therapy till the approval of dabigatran in 2010, and of rivaroxaban and ot...
Na minha lista:
| Publicado no: | Singapore Med J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Singapore Medical Association
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4678403/ https://ncbi.nlm.nih.gov/pubmed/26702159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2015184 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|